
This is an incredibly exciting time for advocates and users of NAD+ as we are seeing a dramatic increase in studies and research related to NMN (Nicotinamide Mononucleotide) supplementation. Not only that, but all of the results from these studies seemingly show nothing but positive and impactful results!
I specifically want to present a few study recaps and highlights that were discussed at last year's Aging Research and Drug Discovery (ARDD) Meeting.
Below you will find two clinical trials that showed NMN improved blood pressure and heart function in humans.
A randomized control trial evaluated the effect of NMN supplementation on cardiovascular function in individuals with high blood pressure. Patients with high blood pressure were divided into two groups:
1. NMN Group: 800mg of NMN daily with lifestyle modifications
2. Lifestyle Mod Group: Lifestyle modifications only

Comments